Lacosamide UCB Union européenne - islandais - EMA (European Medicines Agency)

lacosamide ucb

ucb pharma s.a. - lacosamíð - flogaveiki, partial - antiepileptics, - lacosamide ucb er ætlað eitt og sér og venjulega meðferð í meðferð á hluta-upphaf flog með eða án efri almenn ákvörðun er tekin í fullorðnir, unglingum og börn, frá 4 ára aldri með flogaveiki.

Lamictal Tuggu-/dreifitafla 50 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 50 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 50 mg

Lamictal Tuggu-/dreifitafla 5 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 5 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 5 mg

Lamictal Tuggu-/dreifitafla 25 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 25 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 25 mg

Lamictal Tuggu-/dreifitafla 200 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 200 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 200 mg

Lamictal Tuggu-/dreifitafla 2 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 2 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 2 mg

Lamictal Tuggu-/dreifitafla 100 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

lamictal tuggu-/dreifitafla 100 mg

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 100 mg